ICONIC THERAPEUTICS
Iconic Therapeutics develops and commercializes immunoconjugate proteins that trigger the immune system to destroy invader cells. It is a biopharmaceutical company that has an exclusive license on issued Yale University patents for a novel recombinant protein called hI-con1. hI-con1 binds tissue factor (TF), triggering natural killer cells to selectively destroy pathologic neovascular blood vessels. Such cells include choroidal neovascularization (CNV) associated with wet age-related macular deg... eneration (wet AMD) and TF-expressing cancer cells and tumor-associated pathologic blood vessels (PBV). In addition to this cell-mediated cytotoxicity, hI-con1 may also interrupt the positive feedback loop between tissue factor and vascular endothelial growth factor (VEGF), thereby reducing VEGF levels. Phase 1 studies with hl-con1 are complete and no dose limited toxicities were observed. Evidence of dose-related biologic activity was observed.
ICONIC THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2002-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.iconictherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
(650) 437-1000
Email Addresses:
[email protected]
Total Funding:
82.85 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Google Universal Analytics Global Site Tag Nginx Euro
Similar Organizations
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Current Advisors List
Current Employees Featured
Founder
Investors List
HBM Partners
HBM Partners investment in Venture Round - Iconic Therapeutics
JLABS
JLABS investment in Venture Round - Iconic Therapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Venture Round - Iconic Therapeutics
ATDC
ATDC investment in Venture Round - Iconic Therapeutics
MPM Capital
MPM Capital investment in Venture Round - Iconic Therapeutics
Lundbeckfonden Ventures
Lundbeckfonden Ventures investment in Venture Round - Iconic Therapeutics
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Venture Round - Iconic Therapeutics
Elm Street Ventures
Elm Street Ventures investment in Venture Round - Iconic Therapeutics
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Venture Round - Iconic Therapeutics
Diem Bioventures
Diem Bioventures investment in Venture Round - Iconic Therapeutics
Official Site Inspections
http://www.iconictherapeutics.com
- Host name: staticip2.multiscreensite.com
- IP address: 100.24.208.97
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Iconic Therapeutics"
Iconic Therapeutics - Crunchbase Company Profile
Iconic Therapeutics develops and commercializes immunoconjugate proteins that trigger the immune system to destroy invader cells. See details»
Iconic Therapeutics - 2025 Company Profile & Team - Tracxn
Jun 30, 2025 Iconic Therapeutics - Immunoconjugate proteins that trigger the immune system to destroy invader cells to treat AMD and ocular melanoma.. Acquired by Endpoint Health. โฆ See details»
Iconic Therapeutics 2025 Company Profile: Valuation, โฆ
Information on acquisition, funding, cap tables, investors, and executives for Iconic Therapeutics. Use the PitchBook Platform to explore the full profile. See details»
Iconic Therapeutics - Org Chart, Teams, Culture & Jobs | The Org
View Iconic Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more. See details»
Iconic Therapeutics - Craft
Iconic Therapeutics has 5 employees across 2 locations and $82.5 m in total funding,. See insights on Iconic Therapeutics including office locations, competitors, revenue, financials, โฆ See details»
Iconic Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Iconic Therapeutics, Inc. of South San Francisco, CA. Get the latest business insights from Dun & โฆ See details»
Overview, News & Similar companies - ZoomInfo.com
Jan 5, 2022 View Iconic Therapeutics (www.iconictherapeutics.com) location in California, United States , revenue, industry and description. Find related and similar companies as well โฆ See details»
Iconic Therapeutics, Inc. | MedPath
Open-Label Study of Intravitreal ICON-1 in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD) Phase 2 Terminated Conditions Choroidal โฆ See details»
Iconic Therapeutics Company Profile | Management and
Iconic Therapeutics Profile and History Iconic Therapeutics, Inc. is a venture-backed biopharmaceutical company dedicated to translating an understanding of the role of Tissue โฆ See details»
Iconic Therapeutics Company Profile -Sales, Contacts, Competitors ...
This organization primarily operates in the Pharmaceutical Preparations business / industry within the Chemicals and Allied Products sector. This organization has been operating for โฆ See details»
Iconic Therapeutics company information, funding & investors
Iconic Therapeutics, clinical stage biopharmaceutical company dedicated to translating scientific insight into breakthrough medicines. Here you'll find information about their funding, investors โฆ See details»
Iconic Therapeutics, Inc. Overview | SignalHire Company Profile
Iconic Therapeutics, Inc. is a private company that has been in the industry for 21 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the โฆ See details»
Iconic Therapeutics | Elm Street Ventures - A Yale Focused Venture โฆ
Elm Street Ventures partner Mike Sherman (now retired) was a co-founder of the company, which raised its first capital in 2003, and served as the CEO and Chairman. Iconic raised a โฆ See details»
Iconic Therapeutics - Portfolio Company Profile, Executives and โฆ
See Iconic Therapeutics's complete profile, including its private equity owner and the number of its executive contacts in our database. Iconic Therapeutics is a clinical stage โฆ See details»
Iconic Therapeutics - VentureRadar
"Iconic Therapeutics is a clinical stage biopharmaceutical company dedicated to translating an understanding of the role of Tissue Factor biology to new therapeutics for retinal disease and โฆ See details»
Iconic Therapeutics - Profiles & Contacts - Crunchbase
Iconic Therapeutics develops and commercializes immunoconjugate proteins that trigger the immune system to destroy invader cells. See details»
Iconic Therapeutics, Inc. (Iconic Therapeutics, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธ โฆ
Jun 15, 2025 The purpose of this study is to evaluate the safety and effects of repeated intravitreal injections of ICON-1 0.6 mg administered as maintenance therapy or in โฆ See details»
ICONIC THERAPEUTICS CLOSES SERIES C FINANCING WITH NEW โฆ
Matthias Fehr, Ph.D., CFA, Investment Advisor at HBM Partners, Ltd., said, We believe that Iconic has the potential to be the first company to successfully target Tissue Factor. This historically โฆ See details»
Iconic Therapeutics - VentureRadar
Iconic Therapeutics is a clinical stage biopharmaceutical company dedicated to translating an understanding of the role of Tissue Factor biology to new therapeutics for retinal disease and โฆ See details»
Meet the biotech-company founders driven by their childโs
1 day ago For some parents, finding a cure for their childโs illness is the ultimate motivation to start a company. See details»